
Über diesen Podcast
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
63 Folgen · Technisch nieuws
Pharma and BioTech Daily
Über diesen Podcast
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
Neue Folgen
- GSK Invests $800M in Biologics Facility | Pharma and Biotech Daily14. Okt. · 5 Min.
- Asahi Kasei's $920M AiCuris Buy Leads to FDA OK | Pharma and Biotech Daily13. Okt. · 5 Min.
- GSK AI Partnership & Roche's FDA Win: $117M IPO Buzz | Pharma and Biotech Daily12. Okt. · 5 Min.
- Novartis' Rhapsido FDA Expansion Boosts Revenue Potential | Pharma and Biotech Daily9. Okt. · 5 Min.
- Cerevance's Solengepras Hits Phase 3 Success for Parkinson's | Pharma and Biotech Daily8. Okt. · 5 Min.
- Shionogi Acquires Intrabio for $2B: Rare Disease Focus | Pharma and Biotech Daily7. Okt. · 5 Min.
- Bayer's $2.2B Ohio Site Boosts U.S. Pharma | Pharma and Biotech Daily6. Okt. · 5 Min.
- Novartis's $7.8B mRNA Deal with Abogen | Pharma and Biotech Daily5. Okt. · 5 Min.
- Sanofi's $1B Deal with Regeneron: Immunology Breakthroughs | Pharma and Biotech Daily2. Okt. · 4 Min.
- Eli Lilly's Retatrutide: 25% Weight Loss in Phase 3 Trial! | Pharma and Biotech Daily1. Okt. · 6 Min.